BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.42B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.87B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$704M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$517M |
| 5 |
Nike
NKE
|
+$489M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$301M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$283M |
| 3 |
State Street SPDR S&P Retail ETF
XRT
|
+$156M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$72M |
| 5 |
NVIDIA
NVDA
|
+$68.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.15% |
| 2 | Consumer Discretionary | 6.92% |
| 3 | Financials | 5.66% |
| 4 | Healthcare | 5.15% |
| 5 | Industrials | 3.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Angi Inc
ANGI
$196M
| $130K | ﹤0.01% |
2,293
-1,427
| -38% | -$104K |
|
3102
uniQure
QURE
$3.26B
| $129K | ﹤0.01% |
7,132
-24,332
| -77% | -$425K |
|
3103
Celldex Therapeutics
CLDX
$3.35B
| $129K | ﹤0.01% |
3,781
-10,809
| -74% | -$346K |
|
|
CONN
3104
DELISTED
Conn's Inc.
CONN
| $129K | ﹤0.01% |
8,350
-5,432
| -39% | -$117K |
|
3105
Workhorse Group
WKHS
$33.1M
| $129K | ﹤0.01% |
9
-8
| -47% | -$88.2K |
|
|
FLNA
3106
Filana Therapeutics
FLNA
$45.7M
| $129K | ﹤0.01% |
3,460
-17,094
| -83% | -$724K |
|
3107
Nomad Foods
NOMD
$1.68B
| $128K | ﹤0.01% |
5,679
-4,321
| -43% | -$105K |
|
3108
MannKind Corp
MNKD
$1.2B
| $128K | ﹤0.01% |
34,843
-54,022
| -61% | -$197K |
|
|
OLP
3109
One Liberty Properties
OLP
$537M
| $128K | ﹤0.01% |
4,163
-2,806
| -40% | -$87K |
|
3110
Liberty Energy
LBRT
$3.45B
| $128K | ﹤0.01% |
8,639
-66,059
| -88% | -$845K |
|
|
NGD
3111
DELISTED
New Gold Inc
NGD
| $128K | ﹤0.01% |
71,092
-779
| -1% | -$1.34K |
|
3112
AXT Inc
AXTI
$5.07B
| $126K | ﹤0.01% |
17,953
-6,076
| -25% | -$45.7K |
|
3113
The Joint Corp
JYNT
$119M
| $126K | ﹤0.01% |
3,560
-3,016
| -46% | -$139K |
|
3114
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
| $126K | ﹤0.01% |
1,613
-35,200
| -96% | -$2.8M |
|
|
TWOU
3115
DELISTED
2U Inc
TWOU
| $126K | ﹤0.01% |
316
-280
| -47% | -$113K |
|
3116
Thomson Reuters
TRI
$46B
| $126K | ﹤0.01% |
1,095
+24
| +2% | +$2.68K |
|
3117
Willdan Group
WLDN
$1.29B
| $125K | ﹤0.01% |
4,084
+1,220
| +43% | +$38K |
|
3118
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.81B
| $125K | ﹤0.01% |
+4,764
| New | +$126K |
|
3119
York Water
YORW
$536M
| $125K | ﹤0.01% |
2,777
-1,971
| -42% | -$88K |
|
3120
BrightView Holdings
BV
$1.08B
| $125K | ﹤0.01% |
9,172
-36,837
| -80% | -$498K |
|
|
AZUL
3121
DELISTED
Azul
AZUL
| $124K | ﹤0.01% |
8,259
-2,554
| -24% | -$36.6K |
|
3122
Modine Manufacturing
MOD
$10.8B
| $124K | ﹤0.01% |
13,772
-6,849
| -33% | -$67.4K |
|
3123
Village Farms International
VFF
$302M
| $124K | ﹤0.01% |
+23,482
| New | +$126K |
|
3124
Atara Biotherapeutics
ATRA
$76.7M
| $124K | ﹤0.01% |
534
-1,434
| -73% | -$457K |
|
3125
Organogenesis Holdings
ORGO
$226M
| $123K | ﹤0.01% |
16,202
-57,666
| -78% | -$446K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2022 Portfolio in Review
As of Q1 2022, BNP Paribas Financial Markets held 4,480 positions worth $74.4B, up 5.9% from $70.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $8.44B of net new capital in Q1 2022, opening 238 new positions and adding to 1,135 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $283M trimmed.
- BNP Paribas Financial Markets's largest Q1 2022 buy was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2022, an estimated $2.42B increase.
- BNP Paribas Financial Markets's biggest Q1 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $283M.
- BNP Paribas Financial Markets fully exited Xilinx Inc in Q1 2022, selling an estimated $301M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $74.4B portfolio in Q1 2022.
- BNP Paribas Financial Markets opened 238 new positions and closed 335 in Q1 2022.
- BNP Paribas Financial Markets's portfolio value rose 5.9% quarter-over-quarter to $74.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.